Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

NFκB Dysregulation in the Bone Marrow Niche Drives Epigenomic Reprogramming of Hematopoietic Stem Cells and Myeloid Bias

Jennifer J Chia, Apeksha Singh, Yu-Sheng Eason Lin, Tiffany Tran, Jennifer King, Dinesh S. Rao, Alexander Hoffmann

Blood (2023) 142 (Supplement 1): 4079.

https://doi.org/10.1182/blood-2023-189801

Published: 2023

Journal Articles

Synergism between IGF2BP1 and ETV6-RUNX1 in the Pathogenesis of ETV6-RUNX1 Positive B-Acute Lymphoblastic Leukaemia

Gunjan Sharma, Tiffany Tran, Jaspal Bassi, Amit Kumar Jaiswal, Christine Tso, Ayushi Jain, Jay Singh, Anita Chopra, Archna Singh, Sameer Bakhshi, Dinesh S Rao, Jayanth Kumar Palanichamy

Blood (2021) 138 (Supplement 1): 3483.

https://doi.org/10.1182/blood-2021-150319

Published: 2021

Journal Articles

Development of Notch1 Positive T-Lineage Lymphomas or Splenic Marginal Zone Lymphomas with Pan-Hematopoietic or Pro-B Cell Specific Deletion of Trp53 with Distinct Differentially Dysregulated Pathways

Jayanth Kumar Palanichamy, Tiffany Tran, Jennifer King, Sol Katzman, Gunjan Sharma, Christine Tso, Jorge R Contreras, Thilini Fernando, Jeremy Sanford, Dinesh S Rao

Blood (2021) 138 (Supplement 1): 2229.

https://doi.org/10.1182/blood-2021-150931

Published: 2021

Journal Articles

The RNA Binding Protein IGF2BP3 Is Required for MLL-AF4 Mediated Leukemogenesis

Tiffany Tran, BS, Jaspal Bassi, Neha Nibber, Julia Philipp, Jolene Draper, Tasha Lin, MD, Jayanth Kumar Palanichamy, MDMBBS, Amit Kumar, Oscar Silva, MD PhD, May Paing, Jennifer King, MD, Sol Katzman, Jeremy Sanford, Dinesh S. Rao, MD PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-143181

Published: 2020

Journal Articles

Defining The Role Of Microrna-146a In B Cell Lymphomagenesis

Jorge Contreras, BS, Jayanth Kumar Palanichamy, MD, Tiffany Tran, BS, Dinesh S. Rao, M.D.; Ph.D.

Blood (2013) 122 (21): 3805.

https://doi.org/10.1182/blood.V122.21.3805.3805

Published: 2013

Journal Articles

Role Of Insulin Like Growth Factor mRNA Binding Protein-3 (IGF2BP3) In Mixed Lineage Leukemia (MLL) Positive B-Cell Lymphomas

Jayanth Kumar Palanichamy, MD, Tiffany Tran, BS, Jorge Contreras, BS, Thilini R Fernando, Ph.D., Dinesh S. Rao, M.D.; Ph.D.

Blood (2013) 122 (21): 3816.

https://doi.org/10.1182/blood.V122.21.3816.3816

Published: 2013

NARROW

NFκB Dysregulation in the Bone Marrow Niche Drives Epigenomic Reprogramming of Hematopoietic Stem Cells and Myeloid Bias

Synergism between IGF2BP1 and ETV6-RUNX1 in the Pathogenesis of ETV6-RUNX1 Positive B-Acute Lymphoblastic Leukaemia

Development of Notch1 Positive T-Lineage Lymphomas or Splenic Marginal Zone Lymphomas with Pan-Hematopoietic or Pro-B Cell Specific Deletion of Trp53 with Distinct Differentially Dysregulated Pathways

The RNA Binding Protein IGF2BP3 Is Required for MLL-AF4 Mediated Leukemogenesis

Defining The Role Of Microrna-146a In B Cell Lymphomagenesis

Role Of Insulin Like Growth Factor mRNA Binding Protein-3 (IGF2BP3) In Mixed Lineage Leukemia (MLL) Positive B-Cell Lymphomas

Email alerts

ASH Publications

American Society of Hematology

NFκB Dysregulation in the Bone Marrow Niche Drives Epigenomic Reprogramming of Hematopoietic Stem Cells and Myeloid Bias

Synergism between IGF2BP1 and ETV6-RUNX1 in the Pathogenesis of ETV6-RUNX1 Positive B-Acute Lymphoblastic Leukaemia

Development of Notch1 Positive T-Lineage Lymphomas or Splenic Marginal Zone Lymphomas with Pan-Hematopoietic or Pro-B Cell Specific Deletion of Trp53 with Distinct Differentially Dysregulated Pathways

The RNA Binding Protein IGF2BP3 Is Required for MLL-AF4 Mediated Leukemogenesis

Defining The Role Of Microrna-146a In B Cell Lymphomagenesis

Role Of Insulin Like Growth Factor mRNA Binding Protein-3 (IGF2BP3) In Mixed Lineage Leukemia (MLL) Positive B-Cell Lymphomas

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only